AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 21244474
Drug: Pitavastatin 2
RxNorm normalized name: PITAVASTATIN 2MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pitavastatin 2 mg
Trial: 7423602
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g of ascorbic acid
Trial: 9232342
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g of ascorbic acid
Trial: 9232342
Drug: 4 g
RxNorm normalized name: CTX4 Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 g of ascorbic acid
Trial: 8489978
Drug: Intravenous droperidol
RxNorm normalized name: Droperidol
DrugBank: Droperidol (DB00450)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous droperidol (2.5 mg)
Trial: 3501274
Drug: rIFN-alpha (5.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rIFN-alpha (5.5 megaunits/m2 body surface daily for 21 days, then twice a week for six months)
Trial: 23131287
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine (multienzyme tablets and mosapride dispersible tablets)
Trial: 23131287
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (routine symptomatic treatment)
Trial: 17993948
Drug: Various therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various therapies to maintain hemodynamic stability for organ donation
Trial: 8548117
Drug: Maintaining sinus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintaining sinus rhythm through chronic administration of antiarrhythmic agents
Trial: 7872185
Drug: Enoxaparin 60
RxNorm normalized name: enoxaparin 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 60 mg
Trial: 1963015
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin 5000 IU tds
Trial: 7221357
Drug: 2.4 g
RxNorm normalized name: ZINC OXIDE 12.4 g in 100 g TOPICAL CREAM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.4 g of bacampicillin plus 1.0 g of probenecid
Trial: 7221357
Drug: 1.6 g
RxNorm normalized name: GLYCERIN 1241.6 g in 1 L TOPICAL LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.6 g of bacampicillin plus 1.0 g of probenecid
Trial: 7221357
Drug: 3.5 g
RxNorm normalized name: Calcium 760 MG/3.5 GM Oral Granule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3.5 g of ampicillin plus 1.0 g of probenecid
Trial: 28925969
Drug: Caffeine (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine (3 mg/kg of body mass)
Trial: 31331240
Drug: Standardized protocol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized protocol for postoperative care (4- to 6-day intubation, determined choice, dosage, and duration of sedating medications)
Trial: 30012355
Drug: High-dose oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose oral cholecalciferol (100,000 IU vitamin D3 at baseline and week 2)
Trial: 22687487
Drug: Escitalopram monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram monotherapy plus placebo
Trial: 22687487
Drug: Combination treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatments (bupropion SR + escitalopram or venlafaxine XR + mirtazapine)
Trial: 30113928
Drug: SSRI monotherapy
RxNorm normalized name: Adoptive immunotherapy agent CTL019
DrugBank: Tisagenlecleucel (DB13881)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SSRI monotherapy
Trial: 19625712
Drug: Standard-dose peginterferon
RxNorm normalized name: PEGINTERFERON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose peginterferon alfa‐2b (1.5 microg/kg/week) + ribavirin (800-1400 mg/day)
Trial: 19625712
Drug: Low-dose peginterferon
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose peginterferon alfa‐2b (1.0 microg/kg/week) + ribavirin (800-1400 mg/day)
Trial: 19625712
Drug: Peginterferon alfa‐2a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peginterferon alfa‐2a (180 microg/week) + ribavirin (1000-1200 mg/day)
Trial: 19625712
Drug: Standard-dose peginterferon
RxNorm normalized name: PEGINTERFERON
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose peginterferon alfa‐2b
Trial: 19625712
Drug: Low-dose peginterferon
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose peginterferon alfa‐2b
Trial: 19625712
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with undetectable HCV RNA levels at treatment weeks 4 and 12
Trial: 17452491
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin A injection with 4 sessions of occupational therapy over 4 weeks
Trial: 25808577
Drug: Occupational therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occupational therapy alone
Trial: 15157685
Drug: Tramadol/Acetaminophen (APAP)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol/Acetaminophen (APAP) 75 mg/650 mg
Trial: 11593710
Drug: Continuous epidural
RxNorm normalized name: ACCU-BLOC PERIFIX CONTINUOUS EPIDURAL ANESTHESIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous epidural infusion of droperidol 10 mg in 48 hours
Trial: 11593710
Drug: Bolus doses
RxNorm normalized name: SET,INFUSION,BOLUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bolus doses of droperidol 2.5 mg
Trial: 9689301
Drug: Ammonium solution
RxNorm normalized name: ammonium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ammonium solution
Trial: 8607936
Drug: IVIg 500
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIg 500 mg/kg/month
Trial: 28137517
Drug: Turkish classical
RxNorm normalized name: Turkish Licorice Root
DrugBank: Glycyrrhiza glabra (DB14312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turkish classical music therapy for 30 minutes daily for 7 days (5 days before and 2 days after labor)
Trial: 28137517
Drug: Turkish classical
RxNorm normalized name: Turkish Licorice Root
DrugBank: Glycyrrhiza glabra (DB14312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Turkish classical music therapy
Trial: 28137517
Drug: Routine care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine care and 30 minutes of bed rest daily
Trial: 21632816
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Conventional insulin therapy - CIT)
Trial: 20137621
Drug: Infliximab (IFX)
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab (IFX) 5 mg/kg body weight at 0, 2, and 6 weeks, followed by maintenance therapy every 8 weeks.
Trial: 11242725
Drug: Topical anesthetic
RxNorm normalized name: Topical anesthetic
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical anesthetic gel (20% benzocaine)
Trial: 9133513
Drug: Angina-guided drug
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angina-guided drug therapy
Trial: 9133513
Drug: Ischemia-guided drug
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ischemia-guided drug therapy
Trial: 7595182
Drug: gemfibrozil 1200
RxNorm normalized name: Gemfibrozil
DrugBank: Gemfibrozil (DB01241)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: gemfibrozil 1200 mg day‐1
Trial: 156916
Drug: Fenoterol (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoterol (0.5 mg, inhalation)
Trial: 156916
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide (0.25 mg, inhalation)
Trial: 156916
Drug: Theophylline (240
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Theophylline (240 mg, intravenous)
Trial: 156916
Drug: Disodium cromoglicicum
RxNorm normalized name: BALSALAZIDE DISODIUM
DrugBank: Balsalazide (DB01014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disodium cromoglicicum (20 mg, before tests)
Trial: 21842428
Drug: DepoFoam bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DepoFoam bupivacaine 120 mg
Trial: 17804986
Drug: Nortriptyline plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nortriptyline plus lithium (continuation pharmacotherapy)
Trial: 11517739
Drug: Antibodies to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibodies to tumor necrosis factor-alpha (anti-TNF-a)
Trial: 11517739
Drug: Antibodies to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibodies to interferon-gamma (anti-INF-g)
Trial: 8866937
Drug: L-threo-3,4-dihydroxyphenylserine (L-DOPS)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-threo-3,4-dihydroxyphenylserine (L-DOPS) 100 mg
Trial: 2894232
Drug: Aspirin 300
RxNorm normalized name: aspirin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 300 mg once daily
Trial: 26506070
Drug: 0.1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg/kg oxandrolone orally twice daily for 24 months
Trial: 22067612
Drug: Yoghurts containing
RxNorm normalized name: fish oil (containing omega-3 acids) Injection [Omegaven]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoghurts containing microencapsulated L. reuteri NCIMB 30242
Trial: 18629529
Drug: E (3)
RxNorm normalized name: Estrone (3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E (3) - Epidural infusion initiated 3 min after spinal induction
Trial: 18629529
Drug: E (30)
RxNorm normalized name: ascorbic acid 120 MG / calcium carbonate 200 MG / cholecalciferol 0.41 MG / choline bitartrate 55 MG / ferrous fumarate 27 MG / folic acid 1 MG / niacin 20 MG / potassium iodide 0.15 MG / pyridoxine HCl 50 MG / riboflavin 3 MG / thiamine mononitrate 3 MG / vitamin B 12 8 MCG / vitamin E 0.03 MG / zinc oxide 15 MG Delayed Release Oral Tablet (30) / docosahexaenoic acid 250 MG / eicosapentaenoic acid 0.625 MG Oral Capsule (30) Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E (30) - Epidural infusion initiated 30 min after spinal induction
Trial: 18629529
Drug: E (60)
RxNorm normalized name: caffeine 65 MG / riboflavin 6.25 MG / thiamine 25 MG / vitamin B12 125 MCG / vitamin B6 25 MG Oral Capsule (60) / ibuprofen 400 MG Oral Tablet (60) Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E (60) - Epidural infusion initiated 60 min after spinal induction
Trial: 18629529
Drug: E (90)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: E (90) - Epidural infusion initiated 90 min after spinal induction
Trial: 15232677
Drug: Steroid regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid regimen (prednisone for 4 months)
Trial: 26036529
Drug: Steroid-free regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Steroid-free regimen
Trial: 15232677
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups (steroid-free and steroids)
Trial: 12190655
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone (220 micro g twice daily)
Trial: 7796709
Drug: Fluconazole suspension
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole suspension (100 mg)
Trial: 7796709
Drug: Fluconazole capsule
RxNorm normalized name: Fluconazole
DrugBank: Fluconazole (DB00196)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluconazole capsule (100 mg)
Trial: 2209876
Drug: Oral micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral micronized estradiol (E2), 2 mg
Trial: 2209876
Drug: Conjugated estrogens
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens (Es), 5 mg
Trial: 19023897
Drug: IVRS administration
RxNorm normalized name: Influenza A Virus A/Thailand/8/2022 IVR-237 (H3N2) whole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVRS administration of SIBDQ
Trial: 19023897
Drug: IVRS administration
RxNorm normalized name: Influenza A Virus A/Thailand/8/2022 IVR-237 (H3N2) whole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVRS administration of SIBDQ in active CD
Trial: 19023897
Drug: IVRS administration
RxNorm normalized name: Influenza A Virus A/Thailand/8/2022 IVR-237 (H3N2) whole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVRS administration of SIBDQ in active UC
Trial: 19023897
Drug: IVRS administration
RxNorm normalized name: Influenza A Virus A/Thailand/8/2022 IVR-237 (H3N2) whole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVRS administration of SIBDQ (first vs second administration)
Trial: 11403532
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitors (PPIs), specifically esomeprazole at 40 mg
Trial: 11403532
Drug: Higher doses
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher doses of proton pump inhibitors
Trial: 8146105
Drug: 414 mg
RxNorm normalized name: chloral hydrate 414 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 414 mg nitrate + nitrite and 23 mg vitamin C
Trial: 8146105
Drug: 412 mg
RxNorm normalized name: calcium carbonate 412 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 412 mg nitrate + nitrite and 177 mg vitamin C
Trial: 8146105
Drug: 23 mg
RxNorm normalized name: morphine 0.23 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23 mg nitrate + nitrite and 39 mg vitamin C
Trial: 8146105
Drug: 21 mg
RxNorm normalized name: aspirin 421 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 21 mg nitrate + nitrite and 193 mg vitamin C
Trial: 30336390
Drug: Cannabis use
RxNorm normalized name: Medical Cannabis
DrugBank: Medical Cannabis (DB14009)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cannabis use 12x/month or more during treatment
Trial: 28699427
Drug: Treatment to
RxNorm normalized name: Lice Treatment Topical lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment to reinstate euthyroidism
Trial: 15698513
Drug: Proton pump
RxNorm normalized name: Proton pump inhibitor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proton pump inhibitor (PPI) co-therapy for 6 months
Trial: 15698513
Drug: Chronic COX-2
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic COX-2 therapy
Trial: 15698513
Drug: Chronic NSAID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chronic NSAID therapy
Trial: 11999607
Drug: Inhalation anaesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation anaesthesia with desflurane or sevoflurane
Trial: 11999607
Drug: Propofol administered
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol administered by target controlled infusion
Trial: 10155331
Drug: Epoetin 6000U
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoetin 6000U weekly for 2 months
Trial: 10155331
Drug: Epoetin 9000U
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoetin 9000U weekly for 2 months
Trial: 10155331
Drug: Epoetin 12000U
RxNorm normalized name: Epoetin
DrugBank: Erythropoietin (DB00016)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epoetin 12000U weekly for 2 months
Trial: 10155331
Drug: Sensitivity analysis
RxNorm normalized name: Fluorimax Sensitive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sensitivity analysis on drug administration cost
Trial: 2664718
Drug: Other relaxation
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other relaxation treatments
Trial: 195709
Drug: Radiotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiotherapy with chemotherapy
Trial: 31554423
Drug: Ticagrelor (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ticagrelor (180 mg loading dose, 90 mg twice daily thereafter)
Trial: 31553203
Drug: Clopidogrel (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (600 mg loading dose, 75 mg daily thereafter)
Trial: 27586537
Drug: Glycopyrrolate (GP)
RxNorm normalized name: Glycopyrrolate
DrugBank: Glycopyrronium (DB00986)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate (GP) MDI 18, 9, 4.6, and 2.4 μg, twice daily (BID)
Trial: 27586537
Drug: Glycopyrrolate (GP)
RxNorm normalized name: Glycopyrrolate
DrugBank: Glycopyrronium (DB00986)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glycopyrrolate (GP) MDI 18 μg, twice daily (BID)
Trial: 27586537
Drug: Placebo MDI,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo MDI, twice daily (BID)
Trial: 27586537
Drug: Open-label tiotropium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Open-label tiotropium dry powder inhaler 18 μg, once daily (QD)
Trial: 23925361
Drug: Tocilizumab 8
RxNorm normalized name: tocilizumab 80 MG in 4 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tocilizumab 8 mg/kg every 4 weeks
Trial: 19297346
Drug: Methotrexate starting
RxNorm normalized name: Methotrexate
DrugBank: Methotrexate (DB00563)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Methotrexate starting at 7.5 mg/week titrated to 20 mg/week
Trial: 17491221
Drug: Coronary calcification
RxNorm normalized name: Glebionis coronaria whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Coronary calcification (CC)
Trial: 17491221
Drug: Severity of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Severity of CC and severity of aortic calcification
Trial: 16053368
Drug: 2.5% lidocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5% lidocaine gel
Trial: 12052273
Drug: Intracoronary stenting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary stenting and intravenous glycoprotein IIb/IIIa antagonists
Trial: 10201667
Drug: 10 U/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 U/kg of unfractionated heparin
Trial: 10201667
Drug: 20 U/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 U/kg of unfractionated heparin
Trial: 7601403
Drug: Therapeutic paracentesis
RxNorm normalized name: Moisturel Therapeutic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapeutic paracentesis plus intravenous albumin
Trial: 2118858
Drug: Leuprolide acetate
RxNorm normalized name: Leuprolide Acetate
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leuprolide acetate (LA) 3.75 mg
Trial: 28899844
Drug: Lipid ibuprofen
RxNorm normalized name: guggul lipids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lipid ibuprofen 1200 mg/day
Trial: 28899844
Drug: Soft-gel ibuprofen
RxNorm normalized name: ibuprofen Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft-gel ibuprofen 1200 mg/day
Trial: 28899844
Drug: Soft-gel ibuprofen
RxNorm normalized name: ibuprofen Topical Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soft-gel ibuprofen 2400 mg/day
Trial: 2782362
Drug: Sublingual and
RxNorm normalized name: Buprenorphine and Naloxone Sublingual Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual and oral nifedipine
Trial: 2782362
Drug: Intravenous and
RxNorm normalized name: immune globulin intravenous and subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous and oral ritodrine
Trial: 943354
Drug: Methandrostenolone at
RxNorm normalized name: methandrostenolone
DrugBank: Metandienone (DB13586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methandrostenolone at a dose of 25 mg im.m. per day for the first ten days from the beginning of symptoms
Trial: 31060939
Drug: aPRP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aPRP treatment group
Trial: 28919143
Drug: Nebulized glycopyrrolate
RxNorm normalized name: Glycopyrrolate
DrugBank: Glycopyrronium (DB00986)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized glycopyrrolate 50 μg twice daily (BID)
Trial: 28919143
Drug: Tiotropium 18
RxNorm normalized name: TIOTROPIUM 18MCG CAP,INHL,6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium 18 μg once daily (OD)
Trial: 21692285
Drug: Medication group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication group (Naproxen Sunstained Release Capsule, 2 tablets taken 30 min after operation and then 2 tablets a day before dressing change)
Trial: 19889206
Drug: TachoSil patches
RxNorm normalized name: fibrinogen / thrombin Medicated Patch [TachoSil]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TachoSil patches
Trial: 11354448
Drug: 4.5 ml
RxNorm normalized name: 4.5 ML Triferic 1.5 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.5 ml polylactic acid (PLA) bioabsorbable syndesmotic screw
Trial: 9216530
Drug: Lidocaine/prilocaine cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine/prilocaine cream application